Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
09/02/2004 | US20040170611 culturing an autologous or allogenic dermal papilla cell in the presence of a Wnt polypeptide or a fragment or analog thereof, and grafting the cultured cell onto the skin |
09/02/2004 | US20040170610 Compositions comprising bone marrow cells together with demineralized and/or mineralized bone matrix and uses thereof in the induction of bone and cartilage formation |
09/02/2004 | US20040170604 Genetic engineering; yeast culture product; blood platelet proliferative agents |
09/02/2004 | DE10026789B4 Knorpelersatz und Verfahren zu dessen Herstellung Cartilage replacement and process for its preparation |
09/02/2004 | CA2843744A1 Delta-endotoxin genes and methods for their use |
09/02/2004 | CA2556671A1 Generating teeth from bone marrow cells |
09/02/2004 | CA2516592A1 Hydrogel for separating cell and method of separating cell |
09/02/2004 | CA2516527A1 Endomannosidases in the modification of glycoproteins in eukaryotes |
09/02/2004 | CA2516191A1 Compositions and methods for the detection and treatment of methylthioadenosine phosphorylase deficient cancers |
09/02/2004 | CA2515779A1 Contraceptive method and compositions related to proteasomal interference |
09/02/2004 | CA2515481A1 An expression cassette and vector for transient or stable expression of exogenous molecules |
09/02/2004 | CA2514471A1 Composite materials comprising supported porous gels |
09/01/2004 | EP1452600A1 Receptor and nucleic acid molecule encoding said receptor |
09/01/2004 | EP1452595A1 ES CELLS WITH ENHANCED RNAi EFFECT |
09/01/2004 | EP1452594A1 Inducer for differentiation of embryo stem cells into ectodermal cells, method of obtaining the same and use thereof |
09/01/2004 | EP1452592A1 Rice transposon genes |
09/01/2004 | EP1452587A1 Stem cells originating in salivary duet epithelial cells and use thereof |
09/01/2004 | EP1452586A1 METHOD OF INDUCING DIFFERENTIATION OF MESODERMAL STEM CELLS, ES CELLS OR IMMORTALIZED CELLS INTO NERVOUS SYSTEM CELLS |
09/01/2004 | EP1452542A2 Reshaped human monoclonal antibodies specific for IgE |
09/01/2004 | EP1452541A1 Hepatitis e virus monoclonal antibodies or the binding fragments of it and the use thereof |
09/01/2004 | EP1452190A1 Implant body having a coating of multi block copolymer and polylysine |
09/01/2004 | EP1452189A1 Implant body having a multiblock copolymer coating |
09/01/2004 | EP1452153A1 Treated tissue for implantation and preparation methods |
09/01/2004 | EP1452150A1 Chemical cleaning of biological material |
09/01/2004 | EP1451581A2 Toll-like receptor 3 signaling agonists and antagonists |
09/01/2004 | EP1451571A2 Dosing and administration of therapeutic micro-organs in living subjects and devices and methods for same |
09/01/2004 | EP1451370A2 Chromosomal saturation mutagenesis |
09/01/2004 | EP1451364A2 Methods and compositions for treating hematological disorders using 232, 2059, 10630, 12848, 13875, 14395, 14618, 17692 or 58874 |
09/01/2004 | EP1451344A2 Compositions and methods for use in isolation of nucleic acid molecules |
09/01/2004 | EP1451337A2 Nogo receptor-mediated blockade of axonal growth |
09/01/2004 | EP1451333A2 Ul16 binding protein 4 |
09/01/2004 | EP1451330A1 Methods of preparing a targeting vector and uses thereof |
09/01/2004 | EP1451328A2 Phytases and method for producing these phytases |
09/01/2004 | EP1451325A2 Transcription factor stress-related polypeptides and methods of use in plants |
09/01/2004 | EP1451324A2 G-protein coupled receptor lustr2 and uses thereof |
09/01/2004 | EP1451322A2 Il-21 antagonists |
09/01/2004 | EP1451321A1 A method of genetic screening using an amplifiable gene |
09/01/2004 | EP1451315A2 Human coagulation factor vii polypeptides |
09/01/2004 | EP1451313A2 Method for cloning and expression of bseri restriction endonuclease and bseri methylase in e. coli |
09/01/2004 | EP1451307A2 Type 2 cytokine receptor and nucleic acids encoding same |
09/01/2004 | EP1451306A1 Method and system for myocardial infarction repair |
09/01/2004 | EP1451305A2 Epitope synchronization in antigen presenting cells |
09/01/2004 | EP1451303A1 Detection of haematopoietic stem cells and progeny and uses thereof |
09/01/2004 | EP1451302A1 In vitro reconstituted sheets of human corneal epithelium and method of producing the same |
09/01/2004 | EP1451300A2 Methods and compositions for the use of stromal cells to support embryonic and adult stem cells |
09/01/2004 | EP1451299A2 Tissue engineered cellular sheets, methods of making and use thereof |
09/01/2004 | EP1451298A2 Cell and tissue growth using substances that reversibly bind oxygen |
09/01/2004 | EP1451297A1 Phenotypic screen of chimeric proteins |
09/01/2004 | EP1451296A2 Expression of polypeptides in rod outer segment membranes |
09/01/2004 | EP1451295A2 Methods for mutating genes in cells and animals using insertional mutagenesis |
09/01/2004 | EP1451294A2 Nutrient medium for maintaining neural cells in injured nervous system |
09/01/2004 | EP1451293A2 Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase |
09/01/2004 | EP1451291A2 Methods for identifying, isolating, and controlling the growth of estrogen-responsive cells |
09/01/2004 | EP1451290A2 A unit and a process for carrying out high cell density fermentation |
09/01/2004 | EP1451223A2 Expression control using variable intergenic sequences |
09/01/2004 | EP1451222A2 Novel proteins with il-6 inhibiting activity |
09/01/2004 | EP1451221A2 GIPs, A FAMILY OF POLYPEPTIDES WITH TRANSCRIPTION FACTOR ACTIVITY THAT INTERACT WITH GOODPASTURE ANTIGEN BINDING PROTEIN |
09/01/2004 | EP1451219A1 Nuclear protein "shoca" - a component of the wnt signalling pathway |
09/01/2004 | EP1451218A2 Methods for the treatment and prognosis of leukemia and other cancer types |
09/01/2004 | EP1451217A1 Novel peptides conferring environmental stress resistance and fusion proteins including said peptides |
09/01/2004 | EP1451213A2 Human and murine cytokine polypeptides |
09/01/2004 | EP1451212A2 Structural and cytoskeleton-associated proteins |
09/01/2004 | EP1450858A2 Methods for treating cancer using a combination of a tumor-derived dendritic cell inhibitory factor antagonist and a toll-like receptor agonist |
09/01/2004 | EP1450830A2 Minor histocompatibility antigen ha-1: target antigen for immunotherapy of tumors |
09/01/2004 | EP1450828A2 In situ immunization |
09/01/2004 | EP1450827A1 Two-constituent compositions for the in situ production of cell transplants that comprise fibroblasts and keratinocytes |
09/01/2004 | EP1450752A2 Multivalent streptococcal vaccine compositions and methods for use |
09/01/2004 | EP1450611A2 Method for the generation of antigen-specific lymphocytes |
09/01/2004 | EP1450604A2 Method for extending the useful shelf-life of refrigerated red blood cells by nutrient supplementation |
09/01/2004 | EP1450602A2 Identifying and characterizing genes |
09/01/2004 | EP1368367A4 Polynucleotide constructs for increased lysine production |
09/01/2004 | EP1284596A4 APPARATUS AND PROCESS FOR i IN SITU /i MANUFACTURE OF ESSENCE FROM LIVING, UNCUT PLANTS |
09/01/2004 | EP1274675B1 Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system |
09/01/2004 | EP1121064B1 Method and device for preparing a dental implant by immersion in a mesenchymal cell culture |
09/01/2004 | EP0975764B1 A gene delivery vehicle expressing the apoptosis-inducing proteins vp2 and/or apoptin |
09/01/2004 | EP0973908B1 Plants with controlled side-shoot formation and/or controlled abscission area formation |
09/01/2004 | EP0700442B1 Immortalized human cell lines containing exogenous cytochrome p450 genes |
09/01/2004 | EP0634936B1 Methods for immunocontraception |
09/01/2004 | EP0610254B1 Glial derived neurotrophic factor |
09/01/2004 | CN1526020A Di- or oligomer of a dimer, trimer, quatrometer or pentamer of recombinant fusion proteins. |
09/01/2004 | CN1526013A Lipolytic enzyme genes |
09/01/2004 | CN1526011A Inhibition of apoptosis process and improvement of cell performance |
09/01/2004 | CN1525981A T1R taste receptors and genes encoding same |
09/01/2004 | CN1525864A Mucin peptide with immunoenhancing properties |
09/01/2004 | CN1524952A False virosome vaccine with recombinant replicon of dengue fever virus as carrier |
09/01/2004 | CN1524951A Vaccine for human papiloma virus |
09/01/2004 | CN1524583A Use of gene for expressing Notch-ligand in production of medicinal preparations for immunotherapy |
09/01/2004 | CN1524575A Virulence genes and proteins, and their use |
09/01/2004 | CN1164741C Use of icariin in inducing external oriented differentiation of embryo stem cells |
09/01/2004 | CN1164740C Human cerebral transfer cell line of lung cancer |
09/01/2004 | CN1164739C Cell freeze-storing liquor for raising anabiosis rate of freeze-stored cell |
08/31/2004 | US6784340 Comprises isopentenyltransferase, cytokinin, and/or luciferase, and domain comprising estrogen receptor; for inducing shoot formation in tobacco and lettuce plants |
08/31/2004 | US6784339 By introducing cdna in antisense orientation under regulation of tissue specific promoter; for plants having greater reserve materials (carbohydrates, proteins, fats) without overexpression or phenotype impairment |
08/31/2004 | US6784338 Comprises antisense patatin promoter sequences for formation of granule bound starch synthases; food additives |
08/31/2004 | US6784337 Method of improving nematode resistance in plants via transformation with a DNA encoding a proteinase inhibitor fusion protein |
08/31/2004 | US6784291 Splice-region antisense composition and method |
08/31/2004 | US6784289 Translational regulatory elements |
08/31/2004 | US6783983 Microfiltration; comprises tumor suppressor genes; gene therapy, vaccines |
08/31/2004 | US6783982 Proteins related to neuronal regeneration and uses thereof |
08/31/2004 | US6783980 Nucleotide sequences for use in the generation of gene transfer tools |